Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating eczema from psoriasis, particularly in ambiguous cases.
Todd Schlesinger, MD, discusses how new immunotherapies and multidisciplinary care are reshaping treatment approaches for patients with advanced skin cancers. This content was developed independently ...
In addition to the US, high-dose nusinersen (Spinraza; Biogen) is also approved in the European Union, Japan, and Switzerland. The patients who received nusinersen exhibited a 15.1-point improvement ...
The study, evaluating the efficacy of the combination of efgartigimod alfa and hyaluronidase-qvfc, is the first to ...
Melinda Gooderham, MD, MSc, FRCPC, discusses findings from the Latitude PsO 3001 and Latitude PsO 3002 studies evaluating zasocitinib. This content was developed independently and is not endorsed by ...
The FDA approval of daratumumab and hyaluronidase-fihj for high-risk smoldering MM shifts care beyond watchful waiting, notes Peter Voorhees, MD. AQUILA enrolled 390 high-risk patients randomized 1:1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results